Strides Pharma Science Share Price
1219.80+19.60 (+1.63%)
+40.05% past 1 Year
Corporate filings & documents
Announcements
Completion of USFDA Inspection at the Companys Formulation Facility at Alathur
1 week agoCompletion of USFDA Inspection at the Companys Formulation Facility at Alathur
1 week agoStrides receives USFDA Establishment Inspection Report (EIR) for flagship facility in Bengaluru
1 month agoStrides receives USFDA Establishment Inspection Report (EIR) for flagship facility in Bengaluru
1 month agoVoting results along with Scrutinizers report for 35th AGM.
1 month agoVoting results along with Scrutinizers report for 35th AGM.
1 month agoProceedings of 35th Annual General Meeting of the Company
1 month agoProceedings of 35th Annual General Meeting of the Company
1 month agoTranscript of Earnings Call pertaining to Unaudited Financial Results of the Company for the quarter ended June 30 2026.
1 month agoTranscript of Earnings Call pertaining to Unaudited Financial Results of the Company for the quarter ended June 30 2026.
1 month agoNewspaper advertisement - Unaudited Financial Results for the quarter ended June 30 2026
1 month agoNewspaper advertisement - Unaudited Financial Results for the quarter ended June 30 2026
1 month agoAudio Recording of Earnings Call dated July 31 2026 pertaining to unaudited financial results for Q1 FY27
1 month agoAudio Recording of Earnings Call dated July 31 2026 pertaining to unaudited financial results for Q1 FY27
1 month agoEarnings Presentation for the quarter ended June 30 2026
1 month agoEarnings Presentation for the quarter ended June 30 2026
1 month agoStrides Delivers Steady Performance with Q1FY27; Revenue at Rs. 12 654m Grew 13% YoY; Ex-US Markets Grew 17% YoY
1 month agoStrides Delivers Steady Performance with Q1FY27; Revenue at Rs. 12 654m Grew 13% YoY; Ex-US Markets Grew 17% YoY
1 month agoOutcome of Board Meeting of the Company held on July 31 2026
1 month agoOutcome of Board Meeting of the Company held on July 31 2026
1 month agoEarnings Call to discuss the Unaudited Financial Results of the Company for the quarter ended June 30 2026
1 month agoEarnings Call to discuss the Unaudited Financial Results of the Company for the quarter ended June 30 2026
1 month agoStrides Pharma Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 inter alia to consider and approve the unaudited financial results (standalone and consolidated) of the Company for the quarter ended June 30 2026 amongst other matters.
1 month agoStrides Pharma Science Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 inter alia to consider and approve the unaudited financial results (standalone and consolidated) of the Company for the quarter ended June 30 2026 amongst other matters.
1 month agoBusiness Responsibility and Sustainability Report for FY 2026
2 months agoBusiness Responsibility and Sustainability Report for FY 2026
2 months ago35th Annual General Meeting is scheduled to be held on Friday August 14 2026 at 12:15 hrs IST
2 months ago35th Annual General Meeting is scheduled to be held on Friday August 14 2026 at 12:15 hrs IST
2 months agoAnnual Report for FY 2025-26
2 months agoAnnual Report for FY 2025-26
2 months ago35th Annual General Meeting is scheduled on Friday August 14 2026 at 12:15 HRS IST.
2 months agoCompany has fixed the Record Date for Final Dividend for FY26 as Friday July 31 2026
2 months agoCompany has fixed the Record Date for Final Dividend for FY26 as Friday July 31 2026
2 months agoCertificate in terms of regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018
2 months agoCertificate in terms of regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018
2 months agoUpdate on Completion of Transaction relating to Pivot Path.
2 months agoUpdate on Completion of Transaction relating to Pivot Path.
2 months agoStrides Partners with Ascent Capital to Unlock Value in Pivot Path
2 months agoStrides Partners with Ascent Capital to Unlock Value in Pivot Path
2 months agoStrides Partners with Ascent Capital to Unlock Value in Pivot Path
2 months agoStrides Partners with Ascent Capital to Unlock Value in Pivot Path
2 months agoIntimation regarding closure of Trading Window for the quarter ended June 30 2026.
2 months agoIntimation regarding closure of Trading Window for the quarter ended June 30 2026.
2 months agoIntimation of Schedule of Analyst/ Institutional Investors Meet
3 months agoIntimation of Schedule of Analyst/ Institutional Investors Meet
3 months agoReminder to Shareholders regarding Unclaimed Dividends and Transfer to IEPF
3 months agoReminder to Shareholders regarding Unclaimed Dividends and Transfer to IEPF
3 months agoIntimation of Effective Date for Scheme of Demerger involving Arco Lab Private Limited ("Arco Lab") and ("Pivot Path Private Limited").
3 months agoSchedule of Analyst/ Institutional Investors Meeting - as enclosed.
3 months agoSchedule of Analyst/ Institutional Investors Meet - as enclosed.
3 months agoAnnual reports
Concalls & investor presentations
Jul 2026
May 2026
Jan 2026
Oct 2025
ConcallPresentation
Aug 2025
ConcallPresentation
Jul 2025
ConcallPresentation
May 2025
ConcallPresentation
Jan 2025
ConcallPresentation
Oct 2024
ConcallPresentation
Jul 2024
ConcallPresentation
May 2024
ConcallPresentation
Jan 2024
Oct 2023
ConcallPresentation
Aug 2023
ConcallPresentation
May 2023
ConcallPresentation
Jan 2023
ConcallPresentation
Nov 2022
ConcallPresentation
Jul 2022
ConcallPresentation
May 2022
ConcallPresentation
Feb 2022
ConcallPresentation
Nov 2021
ConcallPresentation
Aug 2021
May 2021
ConcallPresentation
Feb 2021
ConcallPresentation
Oct 2020
ConcallPresentation